Novel drug target may help overcome resistance to EZH2 inhibitors in SMARCB1 mutated cancers
Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors in children.
Source: news-medical.net
Stay updated with breaking news from Baranda Hansen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inhibitors of the protein EZH2 are effective against cancers with SMARCB1 mutations such as rhabdoid tumors in children.